Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1989 Feb 4;298(6669):281–284. doi: 10.1136/bmj.298.6669.281

Lipid peroxides and atherosclerosis.

M D Stringer 1, P G Görög 1, A Freeman 1, V V Kakkar 1
PMCID: PMC1835603  PMID: 2493896

Abstract

Plasma lipid peroxide concentrations were measured in 100 patients with occlusive arterial disease proved angiographically (50 patients with ischaemic heart disease, 50 with peripheral arterial disease) and compared with values in 75 control patients with no clinical evidence of atherosclerosis. Lipid peroxide concentrations were significantly higher in patients both with ischaemic heart disease (median 4.37 mumol/l (interquartile range 3.85-5.75 mumol/l); p less than 0.001) and with peripheral arterial disease (median 4.37 mumol/l (3.88-5.21 mumol/l); p less than 0.001) than in controls (median 3.65 mumol/l (interquartile range 3.29-3.89 mumol/l). Overall there was a significant but weak correlation between plasma lipid peroxide and plasma triglyceride concentrations (rs = 0.25; p less than 0.001) but not between plasma lipid peroxide and plasma total cholesterol concentrations. Furthermore, hypertension, obesity, diabetes, smoking, positive family history, and intake of beta blockers and thiazide diuretics were not associated with significant differences in lipid peroxide values. This study provides clinical support to experimental data indicating that peroxidised lipids may be important in atherogenesis and its complications and also suggests that peroxidised lipids may provide an index of the severity of atherosclerosis.

Full text

PDF
281

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cathcart M. K., Morel D. W., Chisolm G. M., 3rd Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J Leukoc Biol. 1985 Aug;38(2):341–350. doi: 10.1002/jlb.38.2.341. [DOI] [PubMed] [Google Scholar]
  2. Dormandy J. A., Hoare E., Khattab A. H., Arrowsmith D. E., Dormandy T. L. Prognostic significance of rheological and biochemical findings in patients with intermittent claudication. Br Med J. 1973 Dec 8;4(5892):581–583. doi: 10.1136/bmj.4.5892.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Evensen S. A., Galdal K. S., Nilsen E. LDL-induced cytotoxicity and its inhibition by anti-oxidant treatment in cultured human endothelial cells and fibroblasts. Atherosclerosis. 1983 Oct;49(1):23–30. doi: 10.1016/0021-9150(83)90004-7. [DOI] [PubMed] [Google Scholar]
  4. Fogelman A. M., Shechter I., Seager J., Hokom M., Child J. S., Edwards P. A. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci U S A. 1980 Apr;77(4):2214–2218. doi: 10.1073/pnas.77.4.2214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. GLAVIND J., HARTMANN S., CLEMMESEN J., JESSEN K. E., DAM H. Studies on the role of lipoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta. Acta Pathol Microbiol Scand. 1952;30(1):1–6. doi: 10.1111/j.1699-0463.1952.tb00157.x. [DOI] [PubMed] [Google Scholar]
  6. Gray E., Barrowcliffe T. W. Inhibition of antithrombin III by lipid peroxides. Thromb Res. 1985 Jan 15;37(2):241–250. doi: 10.1016/0049-3848(85)90012-x. [DOI] [PubMed] [Google Scholar]
  7. Greenhalgh R. M., Rosengarten D. S., Mervart I., Lewis B., Calnan J. S., Martin P. Serum lipids and lipoproteins in peripheral vascular disease. Lancet. 1971 Oct 30;2(7731):947–950. doi: 10.1016/s0140-6736(71)90269-8. [DOI] [PubMed] [Google Scholar]
  8. Heinle H., Liebich H. The influence of diet-induced hypercholesterolemia on the degree of oxidation of glutathione in rabbit aorta. Atherosclerosis. 1980 Dec;37(4):637–640. doi: 10.1016/0021-9150(80)90071-4. [DOI] [PubMed] [Google Scholar]
  9. Meade T. W., North W. R., Chakrabarti R., Stirling Y., Haines A. P., Thompson S. G., Brozovié M. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980 May 17;1(8177):1050–1054. doi: 10.1016/s0140-6736(80)91498-1. [DOI] [PubMed] [Google Scholar]
  10. Mitchinson M. J., Ball R. Y. Macrophages and atherogenesis. Lancet. 1987 Jul 18;2(8551):146–148. doi: 10.1016/s0140-6736(87)92341-5. [DOI] [PubMed] [Google Scholar]
  11. Nishigaki I., Hagihara M., Tsunekawa H., Maseki M., Yagi K. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med. 1981 Jun;25(3):373–378. doi: 10.1016/0006-2944(81)90096-x. [DOI] [PubMed] [Google Scholar]
  12. Ross R. The pathogenesis of atherosclerosis--an update. N Engl J Med. 1986 Feb 20;314(8):488–500. doi: 10.1056/NEJM198602203140806. [DOI] [PubMed] [Google Scholar]
  13. Sato Y., Hotta N., Sakamoto N., Matsuoka S., Ohishi N., Yagi K. Lipid peroxide level in plasma of diabetic patients. Biochem Med. 1979 Feb;21(1):104–107. doi: 10.1016/0006-2944(79)90061-9. [DOI] [PubMed] [Google Scholar]
  14. Schmitz-Huebner U., Thompson S. G., Balleisen L., Fechtrup C., Grosse-Heitmeyer W., Kirchhof B., Most E., Müller U. S., Seiffert C., Seiffert D. Lack of association between haemostatic variables and the presence or the extent of coronary atherosclerosis. Br Heart J. 1988 Mar;59(3):287–291. doi: 10.1136/hrt.59.3.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Steinbrecher U. P., Parthasarathy S., Leake D. S., Witztum J. L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3883–3887. doi: 10.1073/pnas.81.12.3883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Szamosi T., Gara I., Venekei I., Jávor A., Ceskel R., Knoll J. Serum lipids, lipid peroxides and the care of children with high risk atherosclerotic family history. Atherosclerosis. 1987 Nov;68(1-2):111–115. doi: 10.1016/0021-9150(87)90100-6. [DOI] [PubMed] [Google Scholar]
  17. Szczeklik A., Gryglewski R. J., Domagala B., Dworski R., Basista M. Dietary supplementation with vitamin E in hyperlipoproteinemias: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability. Thromb Haemost. 1985 Aug 30;54(2):425–430. [PubMed] [Google Scholar]
  18. Szczeklik A., Gryglewski R. J., Domagała B., Zmuda A., Hartwich J., Woźny E., Grzywacz M., Madej J., Gryglewska T. Serum lipoproteins, lipid peroxides and prostacyclin biosynthesis in patients with coronary heart disease. Prostaglandins. 1981 Nov;22(5):795–807. doi: 10.1016/0090-6980(81)90219-7. [DOI] [PubMed] [Google Scholar]
  19. Szczeklik A., Gryglewski R. J. Low density lipoproteins (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries. Artery. 1980;7(6):488–495. [PubMed] [Google Scholar]
  20. Therasse J., Lemonnier F. Determination of plasma lipoperoxides by high-performance liquid chromatography. J Chromatogr. 1987 Jan 23;413:237–241. doi: 10.1016/0378-4347(87)80232-3. [DOI] [PubMed] [Google Scholar]
  21. Uysal M., Bulur H., Sener D., Oz H. Lipid peroxidation in patients with essential hypertension. Int J Clin Pharmacol Ther Toxicol. 1986 Sep;24(9):474–476. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES